XTL Biopharmaceuticals acquires 85% of Beyond Air's NeuroNOS subsidiary
Go back to XTL Biopharmaceuticals acquires 85% of Beyond Air's NeuroNOS subsidiary| (NASDAQ: XAIR) | Delayed: 0.48 +0.01 (2.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.47 | 52 Week High | $ | |||
| Open | $0.49 | 52 Week Low | $ | |||
| Day High | $0.52 | P/E | N/A | |||
| Day Low | $0.47 | EPS | $ | |||
| Volume | 431,681 | |||||
| XTL BIOPHARM SP ADR (NASDAQ: XTLB) | Delayed: 2.58 -0.21 (7.53%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.79 | 52 Week High | $1.75 | |||
| Open | $2.74 | 52 Week Low | $0.64 | |||
| Day High | $2.74 | P/E | N/A | |||
| Day Low | $2.52 | EPS | $0.00 | |||
| Volume | 4,195 | |||||
